@article{article, title = {{Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden}}, url = {{http://eprints.whiterose.ac.uk/139917/ }}, year = {{2018}}, month = {{11}}, author = {{Srivastava T and Prabhu VS and Li H and Xu R and Zarabi N and Zhong Y and Pellisier JM and Perini RF and de Wit R and Mamtani R}}, doi = {{10.1016/j.euo.2018.09.012}}, journal = {{European Urology Oncology}}, note = {{Accessed on 2025/06/21}}}